Antonino Di Lorenzo

Publication Activity (10 Years)

Years Active: 2020-2023
Publications (10 Years): 10

Top Topics

Breast Cancer Risk

Diffusion Weighted Imaging

Inflammatory Response

Fluorescent Probe

Top Venues

International journal of molecular sciences

This page only lists publications with an associated author ORCID identifier.

Publications

Chiara Cossu, Antonino Di Lorenzo, Irene Fiorilla, Alberto Maria Todesco, Valentina Audrito, Laura Conti
The Role of the Toll-like Receptor 2 and the cGAS-STING Pathways in Breast Cancer: Friends or Foes? International journal of molecular sciences 25 (1) (2023)
Chiara Cossu, Antonino Di Lorenzo, Irene Fiorilla, Alberto Maria Todesco, Valentina Audrito, Laura Conti
The Role of the Toll-like Receptor 2 and the cGAS-STING Pathways in Breast Cancer: Friends or Foes? International journal of molecular sciences 25 (1) (2023)
Chiara Cossu, Antonino Di Lorenzo, Irene Fiorilla, Alberto Maria Todesco, Valentina Audrito, Laura Conti
The Role of the Toll-like Receptor 2 and the cGAS-STING Pathways in Breast Cancer: Friends or Foes? International journal of molecular sciences 25 (1) (2023)
Giuseppina Barutello, Antonino Di Lorenzo, Alessandro Gasparetto, Chiara Galiazzi, Elisabetta Bolli, Laura Conti, Federica Cavallo
Immunotherapy against the Cystine/Glutamate Antiporter xCT Improves the Efficacy of APR-246 in Preclinical Breast Cancer Models. Biomedicines 10 (11) (2022)
Enza Di Gregorio, Chiara Romiti, Antonino Di Lorenzo, Federica Cavallo, Giuseppe Ferrauto, Laura Conti
RGD_PLGA Nanoparticles with Docetaxel: A Route for Improving Drug Efficiency and Reducing Toxicity in Breast Cancer Treatment. Cancers 15 (1) (2022)
Enza Di Gregorio, Chiara Romiti, Antonino Di Lorenzo, Federica Cavallo, Giuseppe Ferrauto, Laura Conti
RGD_PLGA Nanoparticles with Docetaxel: A Route for Improving Drug Efficiency and Reducing Toxicity in Breast Cancer Treatment. Cancers 15 (1) (2022)
Enza Di Gregorio, Chiara Romiti, Antonino Di Lorenzo, Federica Cavallo, Giuseppe Ferrauto, Laura Conti
RGD_PLGA Nanoparticles with Docetaxel: A Route for Improving Drug Efficiency and Reducing Toxicity in Breast Cancer Treatment. Cancers 15 (1) (2022)
Antonino Di Lorenzo, Elisabetta Bolli, Roberto Ruiu, Giuseppe Ferrauto, Enza Di Gregorio, Lidia Avalle, Aurora Savino, Pietro Poggio, Irene Fiore Merighi, Federica Riccardo, Mara Brancaccio, Federica Cavallo, Federica Cavallo, Laura Conti
Toll-like receptor 2 promotes breast cancer progression and resistance to chemotherapy. Oncoimmunology 11 (1) (2022)
Antonino Di Lorenzo, Elisabetta Bolli, Lidia Tarone, Federica Cavallo, Laura Conti
Toll-Like Receptor 2 at the Crossroad between Cancer Cells, the Immune System, and the Microbiota. International journal of molecular sciences 21 (24) (2020)
Laura Conti, Elisabetta Bolli, Antonino Di Lorenzo, Valentina Franceschi, Francesca Macchi, Federica Riccardo, Roberto Ruiu, Luca Russo, Elena Quaglino, Gaetano Donofrio, Federica Cavallo
Immunotargeting of the xCT Cystine/Glutamate Antiporter Potentiates the Efficacy of HER2-Targeted Immunotherapies in Breast Cancer. Cancer immunology research 8 (8) (2020)